- Pristine raises $5.4 million Series A financing to grow HIPAA-compliant Google Glass apps for healthcare
- The new funding will be used to grow the company’s team, to scale up its footprint in hospitals, clinics, medical schools, and ambulances across the US
- The company is also fielding interest from large pharma, medical device, and manufacturing companies interested in applying Pristine’s secure communication platforms for field service and remote support
- Funding was led by S3 Ventures, an early stage venture capital firm with $185 million under management that focuses on IT solutions providers
From the Pristine press release:
Pristine, developers of the only HIPAA-compliant video streaming and checklist solutions for Google Glass, announced today that it has raised $5.4 million in Series A financing Austin-based S3 Ventures led the oversubscribed round, which also included Capital Factory, HealthFundr, and a syndicate of strategic clients. This new financing enables the company to expand its R&D, sales, marketing, and operations teams, supporting the company’s rapid growth.
“The team at S3 has pioneered cutting-edge developments in medical devices, enterprise health IT solutions, and more,” said Kyle Samani, cofounder and CEO of Pristine. “With our rapid growth, we are thrilled to have partners with a strong track record of guiding early stage companies to success.”
Pristine was born from a common refrain in healthcare: “Hey, can you come over here and look at this?” In response, the company developed EyeSight, the first commercially available, HIPAA-compliant telepresence platform for Google Glass. Pristine is also finding success with EyeSight outside of healthcare, working with pharmaceutical, medical device, and manufacturing companies on remote support and training applications.
“Wearable technologies like Google Glass are revolutionizing how healthcare is delivered, and the Pristine platform is the market leader,” said Brian R. Smith, Managing Director at S3 Ventures. “Current customers are raving about the product, and we are excited to partner with Pristine to continue innovating in healthcare, as well as remote support applications in other industries.”
“We have deployed EyeSight in ERs, ORs, ICUs, ambulances, and even patients’ homes,” added Samani. “We understand that security is paramount. There is a lot of misinformation about Glass and privacy out in the wild; we have gone the extra mile to guarantee security and control for our clients. Our utmost focus on security will fuel our growth as we scale our wearable communication technology throughout healthcare and across other industries.”
Pristine is pioneering the next generation of telepresence in healthcare and other industries. EyeSight, Pristine’s flagship app, enables HIPAA-compliant audio/video streaming across every platform–Mac, PC, iPhone, iPad, Android, Google Glass, and other smart glass devices. EyeSight is currently in use for patient care across ERs, ORs, ICUs, ambulances, as well as in medical education and medical device service. More information can be found at www.pristine.io, pristine.io/blog, and by following @PristineIO on Twitter.
About S3 Ventures
S3 Ventures is an earlier stage venture firm with $185 million under management. The firm is focused on information technology solutions that solve large business problems and in medical devices that improve the human condition. S3 invests primarily in the formative stages of a company and partners with the team to help focus methodically on what it takes to build a successful company. For more information about S3, visithttp://www.s3vc.com.